Financial Shenanigans

The Forensic Verdict

Daqo New Energy's reported numbers tie to an economically observable polysilicon cycle, and the headline accounting shows no restatements, no material weakness, no auditor change, and no regulator action. The forensic risk is structural, not deceptive: a controlling-family/affiliated-group ownership lattice, a separately China-listed operating subsidiary that earned 27–34% of consolidated profits in the boom years, $89M of related-party fixed-asset purchases booked in 2023, a $176M long-lived-asset impairment in 2024 that conveniently reset 2025's depreciable base, and a stock-based-comp charge that exceeded reported operating cash flow in the most recent year. These are underwriting issues, not fraud signals. The single data point that would change the grade is any future PCAOB or audit-committee disclosure naming a control deficiency in the related-party process or in inventory valuation under the lower-of-cost-or-NRV regime that is now active.

Shenanigans scorecard

Breeding Ground

The conditions that make accounting strain easier are present, even though no specific control failure has been disclosed.

Parser Error: syntax error at or near "auditor"

LINE 6: select 'PCAOB inspectability', 'Green', 'Daqo's auditor is PCAOB-registered and located in mainland China...
                                                        ^

LINE 6: select 'PCAOB inspectability', 'Green', 'Daqo's auditor is PCAOB-registered and located in mainland China...
                                                        ^

Parser Error: syntax error at or near "auditor"

LINE 6: select 'PCAOB inspectability', 'Green', 'Daqo's auditor is PCAOB-registered and located in mainland China...
                                                        ^

LINE 6: select 'PCAOB inspectability', 'Green', 'Daqo's auditor is PCAOB-registered and located in mainland China...
                                                        ^

The breeding ground is yellow, not red. Daqo has a credible audit committee, a PCAOB-inspectable Big Four auditor, and an unqualified opinion on internal controls. What it does not have is independence from a controlling-family industrial group. The Xu family controls the listed entity, controls the Daqo Group parent that owns the affiliated suppliers, and now controls a separately China-listed operating subsidiary that holds the actual polysilicon production assets. That structure does not produce shenanigans on its own, but it removes the friction that a more diffuse ownership base would generate around related-party pricing, subsidiary cash distributions, and impairment timing.

Earnings Quality

Reported earnings track polysilicon ASPs faithfully, but four items merit forensic attention: the 2024 impairment, share-based compensation that was 17% of operating income at the cycle peak, government subsidies booked above the line, and the parent-vs-consolidated profit gap created by Xinjiang Daqo's separate listing.

Revenue vs receivables

The 2022 receivables build (DSO 90 days versus 0 in 2020) was unwound in 2023 as the cycle turned and the company collected $1,015M of cash from prior-year sales. That is a feature of the framework-contract pricing model and the post-peak collection cycle, not a revenue-recognition red flag. The 2025 DSO of 74 days is mechanical: the denominator (revenue) collapsed faster than receivables.

Big bath: 2024 impairment cleared the 2025 income statement

The MD&A explicitly states that no impairment was needed in 2025 because "polysilicon selling prices rebounded substantially in 2025, which enhanced the recoverability." That is the standard mechanism of a big-bath: write down the asset base when the cycle is at its worst, then enjoy a lower depreciable base when conditions normalize. It is not unusual for cyclical commodity producers and it is not by itself improper, but the convenient timing — first full year of the new chairman/CEO Xiang Xu, who took the role in August 2023 — should be noted.

Margin reset and stock-based compensation

The $307M SBC charge in 2022 was 12% of operating cash flow that year. In 2025 the same comp pool, at $56M, exceeded reported CFO of $50M. Investors who treat SBC as non-cash are double-counting cash earnings: the share count rose from 65.1M (2018) to 67.7M (2025) and a larger pool was diluted at the ADS level, so the cost is real, just deferred to share dilution rather than payroll cash.

Non-controlling interest: parent shareholders own 65–80% of group profit

The chart matters for an ADS investor. After the 2021 STAR Market IPO of Xinjiang Daqo, between 21% and 34% of group profit accrues to minority Chinese shareholders of the operating subsidiary, not to NYSE ADS holders. Cash dividends from Xinjiang Daqo are subject to PRC distribution rules and carry a 10% withholding tax on remittance to the Cayman parent (5% under the HK treaty path used). That structure is fully disclosed and not a forensic flag in itself, but EPS and cash-yield calculations done on consolidated figures will overstate ADS-attributable economics by 25–35% in normal years.

Cash Flow Quality

The five-year CFO/Net Income of 1.30 looks healthy, but the underlying mix has cycled between three very different drivers — one of which (working-capital release in 2023) is non-repeatable.

CFO vs net income vs FCF

Working-capital decomposition: where did the cash actually come from?

The 2023 CFO of $1,616M is materially flattered by a $1,015M reduction in receivables — the company collected on the cycle-peak 2022 sales after prices had already crashed. Without that collection, 2023 CFO would have been approximately $600M, similar to 2021. The 2025 CFO of $50M is similarly aided by a $96M payables build. The pattern is normal for a cyclical commodity producer; the forensic point is that headline CFO trends in 2023 and 2025 are not durable run-rates.

Hidden vendor financing for capex

This is disclosed in the supplemental schedule of non-cash investing activities. Headline accounts payable of $130M at year-end 2025 understates true vendor obligations by another $279M of construction-in-progress payables — a 3x adjustment. This is standard for a heavy-construction company and is not hidden, but liquidity ratios that use only the AP line will underestimate working-capital obligations.

Free cash flow after the buyback program

The $486M of share repurchases in 2023 represented 96% of that year's FCF. The 2024–2025 buyback authorizations of $100M each were not used (per MD&A, "we have not repurchased our ordinary shares or ADSs pursuant to these share repurchase programs"). That restraint at depressed prices is reasonable; the prior buyback at higher prices in 2023 destroyed value, but is not an accounting issue.

Metric Hygiene

The press releases use a small number of non-GAAP and operating metrics. The hygiene around them is acceptable but not pristine.

The single material hygiene point is the cash-cost framing. Management positions Daqo as one of the world's lowest-cost producers and quotes $6.61/kg for 2025. That is true on the company's definition but the 2025 ASP was $5.25/kg, so Daqo lost money on every kilogram once depreciation and SBC are included. The cash-cost framing is intellectually honest — depreciation is non-cash — but it understates the economic cost that an equity owner ultimately bears.

What to Underwrite Next

The forensic risk does not break the thesis. It does require five specific items on the next-quarter and next-annual diligence list.

Signal that would downgrade the grade. Any of: a regulator inquiry referencing Xinjiang Daqo's STAR-listed disclosures, an audit-committee report disclosing a deficiency in related-party controls, a second long-lived-asset impairment within two years, or a re-acceleration of related-party fixed-asset purchases above $50M per year would push the grade from Elevated to High.

Signal that would upgrade the grade. Two consecutive years of clean impairment, related-party purchases below $5M, allowance-for-credit-loss coverage above 25% of receivables, and a non-GAAP framework that includes SBC would move the grade from Elevated back to Watch.

Investor implication. The forensic findings are a position-sizing limiter, not a thesis breaker. The accounting risk justifies a 10–20% valuation haircut on consolidated earnings to reflect the parent-attributable share, and a further reserve for the lower-of-cost-or-NRV regime that now governs inventory carrying values. Equity should be sized to a level where a third year of losses, a second impairment, and a fully-used $100M buyback program would not change the underwriting. The accounting itself is faithful to the cycle; it is the structural economics of a separately-listed operating subsidiary inside a controlling-family industrial group that requires the discipline.